Shashi Kant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shashi Kant has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Theresa Abdo
Department of Hematology and Oncology, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL 33331, USA
2 shared publications - Zeina Nahleh
Department of Hematology-Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA
2 shared publications - Aaron Sidhu
Department of Hematology and Oncology, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL 33331, USA
1 shared publication - Ahmad Alhalabi
Department of Hematology and Oncology, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL 33331, USA
1 shared publication - Ahmad Alhalabi
Department of Hematology-Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA
1 shared publication - Amanda Stevenson
Department of Hematology-Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA
1 shared publication
Latest Publications
- Open Access
- 9 November 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (11) , 687
Factors Influencing Engagement in Psycho-Oncology Services at a Comprehensive Cancer Center
Background: Psychological distress is common among cancer patients, yet some patients referred to psycho-oncology services do not engage in care. Identifying factors associated with engagement may improve supportive care access and reduce disparities. We evaluated sociodemographic and clinical predictors of psychotherapy utilization among patients referred by oncologists or self-referred to psycho-oncology. Methods: We retrospectively reviewed adults with cancer referred to psycho-oncology services between December 2022 and August 2024, with follow-up through December 2025. The primary outcome was attendance versus nonattendance at the initial psychotherapy appointment. Secondary analysis evaluated total psychotherapy visits. Logistic regression and negative binomial regression identified predictors of initial attendance and subsequent utilization, respectively. Results: Among 404 eligible patients, 98 (24.3%) attended no appointments. Median utilization was 2 visits (IQR, 1–5) over 25.7 months (IQR, 15.1–34.1) of follow-up. In multivariable analysis, nonattendance was associated with lack of religious affiliation (Adjusted OR (aOR), 22.7; 95% CI, 8.52–60.5), less than college education (aOR, 7.56; 95% CI, 2.99–19.3), and referral for anxiety alone (aOR, 4.47; 95% CI, 1.72–11.6), depression alone (aOR, 4.15; 95% CI, 1.19–14.4), or other indications (aOR, 34.8; 95% CI, 9.39–129.1) versus combined anxiety and depression (all p ≤ 0.03). Higher visit rates were associated with virtual visits (Incidence rate ratios (IRR), 2.92; 95% CI, 2.20–3.89), physician referral (IRR, 2.05; 95% CI, 1.49–2.81), later referral, religious affiliation (IRR, 4.05; 95% CI, 2.79–5.88), anxiety/depression referral, and targeted therapy (all p < 0.01). Conclusions: Psycho-oncology engagement varies by educational, social, clinical, and referral factors. Telehealth was associated with greater utilization, while referral timing and source may represent modifiable targets for improving engagement and access to supportive care.
- 9 November 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (11) , 687
Open AccessFactors Influencing Engagement in Psycho-Oncology Services at a Comprehensive Cancer Center
Background: Psychological distress is common among cancer patients, yet some patients referred to psycho-oncology services do not engage in care. Identifying factors associated with engagement may improve supportive care access and reduce disparities. We evaluated sociodemographic and clinical predictors of psychotherapy utilization among patients referred by oncologists or self-referred to psycho-oncology. Methods: We retrospectively reviewed adults with cancer referred to psycho-oncology services between December 2022 and August 2024, with follow-up through December 2025. The primary outcome was attendance versus nonattendance at the initial psychotherapy appointment. Secondary analysis evaluated total psychotherapy visits. Logistic regression and negative binomial regression identified predictors of initial attendance and subsequent utilization, respectively. Results: Among 404 eligible patients, 98 (24.3%) attended no appointments. Median utilization was 2 visits (IQR, 1–5) over 25.7 months (IQR, 15.1–34.1) of follow-up. In multivariable analysis, nonattendance was associated with lack of religious affiliation (Adjusted OR (aOR), 22.7; 95% CI, 8.52–60.5), less than college education (aOR, 7.56; 95% CI, 2.99–19.3), and referral for anxiety alone (aOR, 4.47; 95% CI, 1.72–11.6), depression alone (aOR, 4.15; 95% CI, 1.19–14.4), or other indications (aOR, 34.8; 95% CI, 9.39–129.1) versus combined anxiety and depression (all p ≤ 0.03). Higher visit rates were associated with virtual visits (Incidence rate ratios (IRR), 2.92; 95% CI, 2.20–3.89), physician referral (IRR, 2.05; 95% CI, 1.49–2.81), later referral, religious affiliation (IRR, 4.05; 95% CI, 2.79–5.88), anxiety/depression referral, and targeted therapy (all p < 0.01). Conclusions: Psycho-oncology engagement varies by educational, social, clinical, and referral factors. Telehealth was associated with greater utilization, while referral timing and source may represent modifiable targets for improving engagement and access to supportive care.
- Open Access
Quality-of-Life and Weight Loss Outcomes Following an Individualized Nutrition and Physical Activity Counseling Program in Breast Cancer Survivors: A Prospective Single-Arm Pilot Study
Purpose: Assess the feasibility of a 6-month individualized nutrition counseling and exercise program targeting a 10% body weight loss in breast cancer (BC) survivors, with secondary endpoints assessing metabolic parameters, cardiovascular function, and quality of life. Methods: This single-arm pilot study enrolled BC survivors with body mass index (BMI) ≥ 25 kg/m2 in a counseling program with a registered dietitian, consisting of in-person and telephone visits over six months. Outcomes measured included weight, body composition, blood markers, cardiovascular function, and quality of life at 3 and 6 months. Results: A total of 78 breast cancer survivors were enrolled; 59 remained in the study at Month 3, and 54 completed the 6-month follow-up. The median age of participants was 58.5 years, and the cohort was predominantly White (72.4%). Among the 54 participants who completed 6-month follow-up, 11.1% achieved >10% weight loss and 29.6% achieved >5% weight loss. At 3 months, significant reductions were observed in BMI, body fat composition, and hemoglobin A1c (HbA1c), along with improvements in quality of life, depression, and anxiety. At 6 months, significant reductions were observed in weight, BMI, and body fat composition, with improvements in quality of life and depressive symptoms. Conclusions: This hybrid nutrition and exercise program was associated with observed improvements in weight loss and improved quality of life among BC survivors. Implications for Cancer Survivors: A low-burden, hybrid nutrition and exercise program integrated into routine oncology follow-up may help breast cancer survivors achieve weight loss while improving their quality of life.
Open AccessQuality-of-Life and Weight Loss Outcomes Following an Individualized Nutrition and Physical Activity Counseling Program in Breast Cancer Survivors: A Prospective Single-Arm Pilot Study
Purpose: Assess the feasibility of a 6-month individualized nutrition counseling and exercise program targeting a 10% body weight loss in breast cancer (BC) survivors, with secondary endpoints assessing metabolic parameters, cardiovascular function, and quality of life. Methods: This single-arm pilot study enrolled BC survivors with body mass index (BMI) ≥ 25 kg/m2 in a counseling program with a registered dietitian, consisting of in-person and telephone visits over six months. Outcomes measured included weight, body composition, blood markers, cardiovascular function, and quality of life at 3 and 6 months. Results: A total of 78 breast cancer survivors were enrolled; 59 remained in the study at Month 3, and 54 completed the 6-month follow-up. The median age of participants was 58.5 years, and the cohort was predominantly White (72.4%). Among the 54 participants who completed 6-month follow-up, 11.1% achieved >10% weight loss and 29.6% achieved >5% weight loss. At 3 months, significant reductions were observed in BMI, body fat composition, and hemoglobin A1c (HbA1c), along with improvements in quality of life, depression, and anxiety. At 6 months, significant reductions were observed in weight, BMI, and body fat composition, with improvements in quality of life and depressive symptoms. Conclusions: This hybrid nutrition and exercise program was associated with observed improvements in weight loss and improved quality of life among BC survivors. Implications for Cancer Survivors: A low-burden, hybrid nutrition and exercise program integrated into routine oncology follow-up may help breast cancer survivors achieve weight loss while improving their quality of life.
- Open Access
- 29 December 2025
- Published by Higher State Educational Establishment of Ukraine Bukovinian State Medical University
- Vol. 15 (4(58)) , 120-126
LEVELS OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC PARAMETERS OF THE HEART IN EARLY-ONSET PREECLAMPSIA DURING PREGNANCY
N-terminal pro-brain natriuretic peptide (NT-proBNP) is a cardiac peptide primarily synthesized and secreted by left ventricular myocytes. It is recognized as one of the principal biochemical markers of cardiovascular disorders. Elevation of its concentration has been consistently observed in patients with heart failure. However, investigations into the association between NT-proBNP levels and electrocardiographic or echocardiographic findings in pregnancy-related pathological conditions, particularly preeclampsia, remain limited. The aim of the research. To evaluate the association between NT-proBNP concentrations and electrocardiographic and echocardiographic parameters of the heart in early-onset preeclampsia. Material and methods. A total of 90 pregnant women were enrolled in the study. All participants underwent examination between 32 and 36 weeks of gestation. The main group comprised 60 patients with pregnancies complicated by early-onset moderate preeclampsia. The control group included 30 women with uncomplicated pregnancies. NT-proBNP levels were measured using the MAGLUMI NT-proBNP assay (Shenzhen New Industries Biomedical Engineering Co., Ltd., Shenzhen, China). Venous blood samples were collected once at 08:00 after an overnight fast. Electrocardiography was performed using a Heaco ECG600G six/twelve-channel electrocardiograph. Echocardiography was conducted with a GE Voluson E8 Expert ultrasound system (serial number 3143/1144/0178; GE Healthcare, Austria). The study was approved by the Bioethics Committee of Bukovinian State Medical University (Protocol No. 2 dated 9 February 2015). Numerical data were analysed using statistical methods. The investigation was performed as part of a research project at the Department of Obstetrics and Gynecology, Bukovinian State Medical University (Chernivtsi, Ukraine). Statistical analysis was carried out on a personal computer using Statistica software (Microsoft Excel 2010, Microsoft Office 2010, and MedCalc version 16.1), with application of Student’s t-test for independent samples. This study was conducted as part of the research project entitled “Preservation and Restoration of Reproductive Health in Women and Girls with Obstetric and Gynecological Pathologies” at the Department of Obstetrics and Gynecology, Bukovinian State Medical University; state registration number 0121U110020 (2021–2025). Results. Mean NT-proBNP levels were found to be substantially higher in women with preeclampsia than in the control group (79.5 ± 37.4 pg/mL versus 32.0 ± 12.0 pg/mL; p < 0.001). In patients of main group with early-onset preeclampsia, increased thickness of the left ventricular posterior wall was observed both in diastole (1.10 ± 0.05 cm versus to 0.82 ± 0.05 cm in the CG, p < 0.0001), and in systole (1.30 ± 0.04 cm versus 1.10 ± 0.05 cm, p < 0.0001). Comparable changes were noted for the interventricular septum thickness: 1.30 ± 0.05 cm in systole versus 1.10 ± 0.06 cm (p < 0.0001) and 1.09 ± 0.05 cm in diastole versus 0.80 ± 0.04 cm (p < 0.0001). Alterations in electrocardiographic parameters were identified in the MG compared with women with uncomplicated pregnancies. The duration of the P wave was increased (129.4 ± 9.0 ms versus 98.3 ± 11.4 ms; p < 0.0001), as was the QRS complex (107.9 ± 9.6 ms versus 88.8 ± 10.2 ms; p < 0.0001). Prolongation of the T wave was also observed (261.5 ± 9.2 ms versus 180.2 ± 10.6 ms; p < 0.0001). An increase in the QT/QTc interval was noted (461.7 ± 10.0 ms versus 402.8 ± 10.2 ms; p < 0.0001) Correlations between the parameters examined were established as follows: in women with preeclampsia, a weak positive correlation was observed between plasma NT-proBNP levels and interventricular septum thickness in diastole (r = 0.291; p = 0.0093), together with a weak negative correlation with the QT/QTc interval (r = −0.21; p = 0.001). In the CG, NT-proBNP levels exhibited a moderate positive correlation with left ventricular posterior wall thickness in diastole (r = 0.312; p = 0.0089) and a weak negative correlation with the QT/QTc interval (r = −0.205; p = 0.02). Conclusions. 1. Plasma levels of the cardiac peptide NT-proBNP are markedly elevated in women with pregnancies complicated by preeclampsia. 2. Electrocardiographic and echocardiographic parameters obtained in women with early-onset moderate preeclampsia are consistent with early manifestations of left ventricular hypertrophy. 3. Increased thickness of the ventricular walls and interventricular septum represents a morphological marker of myocardial remodelling in response to haemodynamic overload. 4. Electrocardiographic findings—prolongation of the PR, QRS, and QT intervals together with increased duration of the P and T waves—indicate delayed impulse conduction in the myocardium as well as potential alterations in repolarisation processes in the context of moderate preeclampsia.
- 29 December 2025
- Published by Higher State Educational Establishment of Ukraine Bukovinian State Medical University
- Vol. 15 (4(58)) , 120-126
Open AccessLEVELS OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC PARAMETERS OF THE HEART IN EARLY-ONSET PREECLAMPSIA DURING PREGNANCY
N-terminal pro-brain natriuretic peptide (NT-proBNP) is a cardiac peptide primarily synthesized and secreted by left ventricular myocytes. It is recognized as one of the principal biochemical markers of cardiovascular disorders. Elevation of its concentration has been consistently observed in patients with heart failure. However, investigations into the association between NT-proBNP levels and electrocardiographic or echocardiographic findings in pregnancy-related pathological conditions, particularly preeclampsia, remain limited. The aim of the research. To evaluate the association between NT-proBNP concentrations and electrocardiographic and echocardiographic parameters of the heart in early-onset preeclampsia. Material and methods. A total of 90 pregnant women were enrolled in the study. All participants underwent examination between 32 and 36 weeks of gestation. The main group comprised 60 patients with pregnancies complicated by early-onset moderate preeclampsia. The control group included 30 women with uncomplicated pregnancies. NT-proBNP levels were measured using the MAGLUMI NT-proBNP assay (Shenzhen New Industries Biomedical Engineering Co., Ltd., Shenzhen, China). Venous blood samples were collected once at 08:00 after an overnight fast. Electrocardiography was performed using a Heaco ECG600G six/twelve-channel electrocardiograph. Echocardiography was conducted with a GE Voluson E8 Expert ultrasound system (serial number 3143/1144/0178; GE Healthcare, Austria). The study was approved by the Bioethics Committee of Bukovinian State Medical University (Protocol No. 2 dated 9 February 2015). Numerical data were analysed using statistical methods. The investigation was performed as part of a research project at the Department of Obstetrics and Gynecology, Bukovinian State Medical University (Chernivtsi, Ukraine). Statistical analysis was carried out on a personal computer using Statistica software (Microsoft Excel 2010, Microsoft Office 2010, and MedCalc version 16.1), with application of Student’s t-test for independent samples. This study was conducted as part of the research project entitled “Preservation and Restoration of Reproductive Health in Women and Girls with Obstetric and Gynecological Pathologies” at the Department of Obstetrics and Gynecology, Bukovinian State Medical University; state registration number 0121U110020 (2021–2025). Results. Mean NT-proBNP levels were found to be substantially higher in women with preeclampsia than in the control group (79.5 ± 37.4 pg/mL versus 32.0 ± 12.0 pg/mL; p < 0.001). In patients of main group with early-onset preeclampsia, increased thickness of the left ventricular posterior wall was observed both in diastole (1.10 ± 0.05 cm versus to 0.82 ± 0.05 cm in the CG, p < 0.0001), and in systole (1.30 ± 0.04 cm versus 1.10 ± 0.05 cm, p < 0.0001). Comparable changes were noted for the interventricular septum thickness: 1.30 ± 0.05 cm in systole versus 1.10 ± 0.06 cm (p < 0.0001) and 1.09 ± 0.05 cm in diastole versus 0.80 ± 0.04 cm (p < 0.0001). Alterations in electrocardiographic parameters were identified in the MG compared with women with uncomplicated pregnancies. The duration of the P wave was increased (129.4 ± 9.0 ms versus 98.3 ± 11.4 ms; p < 0.0001), as was the QRS complex (107.9 ± 9.6 ms versus 88.8 ± 10.2 ms; p < 0.0001). Prolongation of the T wave was also observed (261.5 ± 9.2 ms versus 180.2 ± 10.6 ms; p < 0.0001). An increase in the QT/QTc interval was noted (461.7 ± 10.0 ms versus 402.8 ± 10.2 ms; p < 0.0001) Correlations between the parameters examined were established as follows: in women with preeclampsia, a weak positive correlation was observed between plasma NT-proBNP levels and interventricular septum thickness in diastole (r = 0.291; p = 0.0093), together with a weak negative correlation with the QT/QTc interval (r = −0.21; p = 0.001). In the CG, NT-proBNP levels exhibited a moderate positive correlation with left ventricular posterior wall thickness in diastole (r = 0.312; p = 0.0089) and a weak negative correlation with the QT/QTc interval (r = −0.205; p = 0.02). Conclusions. 1. Plasma levels of the cardiac peptide NT-proBNP are markedly elevated in women with pregnancies complicated by preeclampsia. 2. Electrocardiographic and echocardiographic parameters obtained in women with early-onset moderate preeclampsia are consistent with early manifestations of left ventricular hypertrophy. 3. Increased thickness of the ventricular walls and interventricular septum represents a morphological marker of myocardial remodelling in response to haemodynamic overload. 4. Electrocardiographic findings—prolongation of the PR, QRS, and QT intervals together with increased duration of the P and T waves—indicate delayed impulse conduction in the myocardium as well as potential alterations in repolarisation processes in the context of moderate preeclampsia.